Label: REZAMID- sulfur and resorcinol lotion
- NDC Code(s): 11086-022-01
- Packager: Summers Laboratories Inc
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
- Marketing Status: OTC monograph final
DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Drug Label Information
Updated January 12, 2023
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- ACTIVE INGREDIENTS
- PURPOSE
- USE
- WARNINGS
- DO NOT USE
- WHEN USING
- STOP USE
-
DIRECTIONS
- shake very well before using
- clean the skin thoroughly before applying this product
- cover the entire affected area with a thin layer one to three times daily
- because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor
- if bothersome dryness or peeling occurs, reduce application to once a day or every other day
-
INACTIVE INGREDIENTS
water, SD-40 alcohol 28%, zinc oxide, talc, titanium dioxide, propylene glycol, attapulgite, lauramide DEA, iron oxides, sodium bisulfite, PEG-8 laurate, parachlorometaxylenol, hydroxyethylcellulose, sodium chloride, sodium polynapthalene sulfonate, EDTA, methyl paraben, xanthan gum, butylparaben, fragrance, simethicone.
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
REZAMID
sulfur and resorcinol lotionProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:11086-022 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength SULFUR (UNII: 70FD1KFU70) (SULFUR - UNII:70FD1KFU70) SULFUR 5 g in 100 mL RESORCINOL (UNII: YUL4LO94HK) (RESORCINOL - UNII:YUL4LO94HK) RESORCINOL 2 g in 100 mL Inactive Ingredients Ingredient Name Strength WATER (UNII: 059QF0KO0R) ALCOHOL (UNII: 3K9958V90M) ZINC OXIDE (UNII: SOI2LOH54Z) TALC (UNII: 7SEV7J4R1U) TITANIUM DIOXIDE (UNII: 15FIX9V2JP) PROPYLENE GLYCOL (UNII: 6DC9Q167V3) ATTAPULGITE (UNII: U6V729APAM) LAURIC DIETHANOLAMIDE (UNII: I29I2VHG38) FERRIC OXIDE RED (UNII: 1K09F3G675) SODIUM BISULFITE (UNII: TZX5469Z6I) PEG-8 LAURATE (UNII: 762O8IWA10) CHLOROXYLENOL (UNII: 0F32U78V2Q) HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) (UNII: 8136Y38GY5) SODIUM CHLORIDE (UNII: 451W47IQ8X) SODIUM NAPHTHALENESULFONATE (UNII: D3F8YRX7TP) EDETIC ACID (UNII: 9G34HU7RV0) METHYLPARABEN (UNII: A2I8C7HI9T) XANTHAN GUM (UNII: TTV12P4NEE) BUTYLPARABEN (UNII: 3QPI1U3FV8) DIMETHICONE (UNII: 92RU3N3Y1O) SILICON (UNII: Z4152N8IUI) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:11086-022-01 56.7 mL in 1 BOTTLE; Type 0: Not a Combination Product 10/30/2013 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC monograph final M006 10/30/2013 Labeler - Summers Laboratories Inc (002382612)